Insilico Research Uses AI and RNA to Reprogram Immune Cells

Insilico Medicine launched a research initiative utilizing artificial intelligence to design cellular treatments for age related conditions. The process uses machine learning to identify surface targets on aging immune cells and delivers circular RNA instructions to direct cellular removal.